Contact Us
Drug Search Results
More Filters [+]

Parecoxib

Alternative Names: parecoxib, dynastat
Latest Update: 2024-12-09
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: COX2 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Australia | Austria | Bangladesh | Belgium | Brazil | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Estonia | European Medicines Agency | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Italy | Jordan | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Mexico | Morocco | Netherlands | New Zealand | Norway | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sweden | Taiwan | Thailand | Tunisia | Ukraine | United Arab Emirates | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Parecoxib

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Pain, Postoperative|Pain Unspecified|Anesthesia Related|Shoulder Pain|Anterior Cruciate Ligament Injuries|Ureteral Calculi|Emergence Delirium|Ureterolithiasis|Renal Colic|Morphine Dependence|Depressive Disorder|Seizures|Chronic Pain|Liver Cancer|Hemangioma|Scoliosis|Gastrointestinal Cancer|Insulin Resistance|Osteoarthritis|Inflammation

Phase 3: Rib Fractures|Morphine Dependence|Osteoarthritis, Knee|Anesthesia Related|Pain Unspecified|Pain, Postoperative|Renal Colic|Anemia, Sickle Cell|Liver Cancer|Total Knee Arthroplasty

Phase 2: Pancreatitis, Acute|Tibial Fractures|Femoral Fractures|Pain, Postoperative|Shoulder Pain|Subarachnoid Hemorrhage|Pharyngitis

Phase 1: Pain, Postoperative

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ChiCTR2500095107

N/A

Not yet recruiting

Unknown

2027-09-27

PARISAH

P2

Not yet recruiting

Subarachnoid Hemorrhage

2027-01-01

AOPC

N/A

Not yet recruiting

Chronic Pain|Pain, Postoperative

2026-12-31

PRECISE

P2

Not yet recruiting

Pancreatitis, Acute

2026-09-30

Recent News Events

Date

Type

Title

03/18/2024

PubMed

 The Efficacy of the Combination of Continuous Femoral Nerve Block and Intravenous Parecoxib on Rehabilitation in Patients Undergoing Total Knee Arthroplasty: A Double-Blind, Randomized Clinical Trial.

12/01/2023

PubMed

 Analgesic Effectiveness of Dinalbuphine Sebacate in Video-Assisted Thoracoscopic Wedge Resection and Its Effect on Reducing Postoperative Pulmonary Complications: A Retrospective Cohort Study.

10/23/2023

News Article

 Hybrid Aircraft Market News, Trends, Share and Growth, Current Growth Dynamics, Future Trends to 2032

09/22/2023

News Article

 Hybrid Aircraft Market Competitive Scenario With Impact Of Drivers And Challenges from 2022 to 2031

09/18/2023

News Article

 Vietnam Hybrid Aircraft Market Outlook, Share, Key Players, Revenue, Size, and Forecast to 2023 to 2032

02/21/2022

News Article

 Alfa Chemistry Launches API Research & Development Platform for the Pharmaceutical Industry

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions